Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Health Claims and Doses of Fish Oil Supplements in the US.
Assadourian JN, Peterson ED, McDonald SA, Gupta A, Navar AM. Assadourian JN, et al. Among authors: navar am. JAMA Cardiol. 2023 Oct 1;8(10):984-988. doi: 10.1001/jamacardio.2023.2424. JAMA Cardiol. 2023. PMID: 37610733 Free PMC article.
Equitable and Informed Consent in Genetic Studies.
Navar AM, Khan SS. Navar AM, et al. JAMA Cardiol. 2023 Jan 1;8(1):42-43. doi: 10.1001/jamacardio.2022.4142. JAMA Cardiol. 2023. PMID: 36383369 No abstract available.
Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) Registry.
Navar AM, Peterson ED, Li S, Robinson JG, Roger VL, Goldberg AC, Virani S, Wilson PWF, Nanna MG, Lee LV, Elassal J, Wang TY. Navar AM, et al. Circ Cardiovasc Qual Outcomes. 2018 Mar;11(3):e004249. doi: 10.1161/CIRCOUTCOMES.117.004249. Circ Cardiovasc Qual Outcomes. 2018. PMID: 29545393 Free PMC article. No abstract available.
Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry.
Nanna MG, Navar AM, Zakroysky P, Xiang Q, Goldberg AC, Robinson J, Roger VL, Virani SS, Wilson PWF, Elassal J, Lee LV, Wang TY, Peterson ED. Nanna MG, et al. Among authors: navar am. JAMA Cardiol. 2018 Aug 1;3(8):739-748. doi: 10.1001/jamacardio.2018.1511. JAMA Cardiol. 2018. PMID: 29898219 Free PMC article.
Medication Discontinuation in the IMPROVE-IT Trial.
Navar AM, Roe MT, White JA, Cannon CP, Lokhnygina Y, Newby LK, Giugliano RP, Tershakovec AM, Braunwald E, Califf RM, Blazing MA. Navar AM, et al. Circ Cardiovasc Qual Outcomes. 2019 Jan;12(1):e005041. doi: 10.1161/CIRCOUTCOMES.118.005041. Circ Cardiovasc Qual Outcomes. 2019. PMID: 30630361 Free PMC article. Clinical Trial.
184 results